interleukin-17


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to interleukin-17: IL-17F

in·ter·leu·kin-17

(in'tĕr-lū'kin),
A proinflammatory cytokine made by T cells.

in·ter·leu·kin-17

(in'tĕr-lū'kin)
A proinflammatory cytokine made by T cells.

interleukin-17

Abbreviation: IL-17
A cytokine produced by memory T lymphocytes that stimulates the proliferation of T cells and the differentiation of neutrophils.
See also: interleukin

interleukin-17

,

IL-17

A cytokine produced by memory T lymphocytes that stimulates the proliferation of T cells and the differentiation of neutrophils.
References in periodicals archive ?
Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis.
The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
In the study, levels of interleukin-17 were brought down by vitamin D when it was added to blood samples taken from 28 patients.
In the first study, researchers assessed brodalumab (AMG 827), a human anti-interleukin-17RA monoclonal antibody that antagonizes the interleukin-17 pathway, in 198 patients at 23 international sites.
The new animal data demonstrate that oral administration of Guanilib significantly reduces gastrointestinal (GI) inflammation, and confirm earlier evidence of down-regulation of interleukin-17 (IL-17), IL-23, and tumor necrosis factor (TNF), key cytokines that are known to be involved in etiology of IBD in humans.
About Brodalumab (AMG 827) Brodalumab is a novel human monoclonal antibody that binds to the interleukin-17 (IL-17) receptor and inhibits inflammatory signaling by blocking the binding of several IL-17 ligands to the receptor.
Marsha Wills-Karp and her colleagues have identified the pro-inflammatory protein, interleukin-17 (IL-17A), as the molecular tipping point that upsets a delicate balance between underlying mild disease and more severe asthma, reports Nature.
Proof-Of-Concept Data of Systemic Administration of Orally Active Small Molecule Antagonists of Interleukin-17 Selected for Presentation
Interleukin-17 (IL-17), an immune system cell involved in proinflammatory response, is a potent regulator of neutrophils (white blood cells).
com/research/k6xqfb/dermatology) has announced the addition of the "Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment" report to their offering.